首页> 美国卫生研究院文献>Frontiers in Endocrinology >Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications
【2h】

Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications

机译:乳头状甲状腺微癌:高风险特征的发生率及其预后意义。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: The current management of papillary thyroid micro carcinoma (PTMC) has become more conservative. However, high-risk characteristics that can only be revealed post-surgically exist. Patients and clinicians need to estimate the risks and understand the prognostic meaning of these factors.>Methods: We retrospectively analyzed 246 consecutive patients with PTMC who underwent surgery at our institution between 2015 and 2017. Clinical and histopathological parameters that may indicate recurrent disease were investigated. The responses to therapy in cases with different risks of recurrence were analyzed.>Results: A total of 79.26% (195/246) of patients received total thyroidectomy (TT), of whom 177 (90.77%) also received central lymph node dissection. Radioiodine ablation (RAI) was applied in 64.23% (158/246) of patients. Intermediate-high risk features were identified in 27.64% (68/246) after primary treatment. After a median follow-up of 18 months (range, 6–39 months), 121 of 158 (76.58%) patients who received TT+RAI were evaluated as an excellent response. An incomplete response (IR) was observed in 14.56% (23/158) of this group of PTMC. Multivariate analysis identified extra thyroid extension (P = 0.001) and intermediate-high risk stratification (P = 0.014) as significant and independent risk factors for an IR.>Conclusions: A total of 27.64% of PTMC cases evaluated as a low risk of recurrence pre-surgery showed intermediate to high risk disease post-surgery, and this leads to a higher rate of IR.
机译:>背景:目前,甲状腺乳头状癌的治疗更为保守。但是,存在只能在手术后才能发现的高风险特征。患者和临床医生需要估计风险并了解这些因素的预后意义。>方法:我们回顾性分析了2015年至2017年间在本机构接受手术的246例PTMC连续患者。临床和组织病理学参数可能表明已对复发性疾病进行了调查。分析了具有不同复发风险的患者对治疗的反应。>结果:共有79.26%(195/246)的患者接受了全甲状腺切除术(TT),其中177例(90.77%)接受中央淋巴结清扫术。 64.23%(158/246)的患者接受了放射碘消融(RAI)。初次治疗后,有27.64%(68/246)的患者具有中高危特征。在中位随访18个月(范围6-39个月)后,接受TT + RAI治疗的158例患者中有121例(76.58%)被评价为良好的反应。在这组PTMC中,有14.56%(23/158)的患者观察到不完全应答(IR)。多变量分析确定了额外的甲状腺扩展(P = 0.001)和中高危分层(P = 0.014)是IR的重要和独立危险因素。>结论:总共评估了PTMC病例的27.64%由于术前复发风险低,表明术后疾病处于中等至高危疾病,因此导致IR发生率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号